<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-viruses-11-00490">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Musharrafieh</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Diesing</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Marty</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor</article-title>
  <source>J. Virol.</source>
  <year>2019</year>
  <volume>93</volume>
  <fpage>e02221-18</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02221-18</pub-id>
  <pub-id pub-id-type="pmid">30674624</pub-id>
 </element-citation>
</ref>
